Question follow-through · 594
Coronavirus: Vaccination
To ask the Secretary of State for Health and Social Care, what recent assessment his Department has made of the potential risk of people with partial trisomy experiencing heart complications following an mRNA vaccine; and if his Department will take steps
About this written question
A written question asks a government minister for information in writing. Parliament publishes the question and any answer.
- Answering body
- Department of Health and Social Care
- Tabled
- 18 Jul 2024
- Target answer date
- 23 Jul 2024
- Answer
- 21 Aug 2024 · 34 calendar days after tabling
Elapsed calendar days describe the record timeline, not whether Parliament considers an answer on time.
More questions by this MP on Health and care
- Covid-19 Inquiry · 23 Jul 2024
- Hospices: Finance · 23 Jul 2024
- Palliative Care: Integrated Care Boards · 23 Jul 2024
- Health Insurance: Private Sector · 23 Jul 2024
- Heart Diseases: Screening · 4 Sept 2024
Shared topic keywords suggest a connection; they do not establish a follow-up.
Votes on this topic
- Terminally Ill Adults (End of Life) Bill: Second Reading · 11 Sept 2026
- Health Bill: Report Stage: Amendment 1 · 8 Sept 2026
- Health Bill: Report Stage: New Clause 143 · 8 Sept 2026
These Commons divisions share a topic label. The question did not necessarily lead to a vote.
Recorded timeline
18 Jul 2024
Question tabled
To ask the Secretary of State for Health and Social Care, what recent assessment his Department has made of the potential risk of people with partial trisomy experiencing heart complications following an mRNA vaccine; and if his Department will take steps
23 Jul 2024
Target answer date
Date supplied by the official written-questions record.
21 Aug 2024
Answer published
There has been no formal review of the potential risk of people with partial trisomy experiencing heart complications following an mRNA vaccine, although the safety of vaccines is continually monitored by the independent Medicine and Healthcare products R...
Official data retrieved 27 Sept 2026.
Later records
Possible follow-up questions
Strong links require the same MP, department and exact heading. Other same-department questions are shown as unreviewed candidates, not as confirmed follow-ups. No debate link is asserted unless a stable source relationship exists.
Covid-19 Inquiry
23 Jul 2024 · To ask the Secretary of State for Health and Social Care, with reference to the Prime Minister's Written Statement of 18 July 2024 on the UK Covid-19 Inquiry Module 1 Report, HCWS11, whether the Prime Minister's personal commitment to each and every famil
Hospices: Finance
23 Jul 2024 · To ask the Secretary of State for Health and Social Care, how much grant funding each Integrated Care Board in England is providing for hospice funding for (a) children's and (b) other hospices over the 2024-25 financial year.
Palliative Care: Integrated Care Boards
23 Jul 2024 · To ask the Secretary of State for Health and Social Care, what assessment he has made of the performance of Integrated Care Boards in England in fulfilling their duty to commission palliative and end of life care.
Health Insurance: Private Sector
23 Jul 2024 · To ask the Secretary of State for Health and Social Care, if he will make an assessment of the potential impact of fee setting and de-recognition procedures on the (a) cost and (b) availability of private medical insurance.
Heart Diseases: Screening
4 Sept 2024 · To ask the Secretary of State for Health and Social Care, if he will make an assessment of the potential impact of providing annual ECGs to young people on the number of victims of sudden cardiac death; and if he will hold discussions with his Italian cou
Respiratory Syncytial Virus: Vaccination
9 Sept 2024 · To ask the Secretary of State for Health and Social Care, for what reason the respiratory syncytial virus vaccination programme does not include people who are 80 or older.
Coronavirus: Vaccination
9 Oct 2024 · To ask the Secretary of State for Health and Social Care, what modifications have been made to existing Covid-19 vaccine products; for what reasons were those modifications made; and when those modifications were approved by the Medicines and Healthcare P
Coronavirus: Vaccination
9 Oct 2024 · To ask the Secretary of State for Health and Social Care, for what reason the MHRA uses observed analyses instead of expected analyses in assessing the safety of Covid-19 vaccines.
Vaccine Damage Payment Scheme
16 Oct 2024 · To ask the Secretary of State for Health and Social Care, if he will take steps to provide (a) healthcare and (b) financial support to people whose applications to the Vaccine Damage Payments Scheme were rejected on the basis that they do not have a sever
Coronavirus: Vaccination
16 Oct 2024 · To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 14 October 2024 to Question 8098 on Coronavirus: Vaccination, whether any line extensions to Covid-19 vaccinations have been authorised to tackle reported adverse side eff
Vaccine Damage Payment Scheme
23 Oct 2024 · To ask the Secretary of State for Health and Social Care, if he will meet with Professor Adam Finn to discuss the Vaccine Damage Payment Scheme (a) 60% threshold, (b) levels of payments in the context of levels of inflation and (c) the potential impact of
Coronavirus: Vaccination
23 Oct 2024 · To ask the Secretary of State for Health and Social Care, when the use of the AstraZeneca Covid-19 vaccine Vaxrevia ended in the UK; and for what reason that vaccine is no longer available.